Lipopolysaccharide Animal Models for Parkinson's Disease
Lipopolysaccharide (LPS), an endotoxin from Gram-negative bacteria, acts as a potent stimulator of microglia and has been used to study the inflammatory process in the pathogenesis of Parkinson's disease (PD) and anti-inflammatory therapy for PD treatment. Here, we review the growing body of li...
Saved in:
| Main Authors: | Mei Liu, Guoying Bing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.4061/2011/327089 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Animal Models of Parkinson's Disease
by: Yuzuru Imai, et al.
Published: (2011-01-01) -
Limitations of Animal Models of Parkinson's Disease
by: J. A. Potashkin, et al.
Published: (2011-01-01) -
Animal Models of Parkinson's Disease 2012
by: Yuzuru Imai, et al.
Published: (2012-01-01) -
Toxin-Induced and Genetic Animal Models of Parkinson's Disease
by: Shin Hisahara, et al.
Published: (2011-01-01) -
Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
by: Kyota Fujita, et al.
Published: (2011-01-01)